240
Participants
Start Date
July 26, 2018
Primary Completion Date
April 29, 2022
Study Completion Date
September 6, 2023
PLX-PAD
PLX-PAD (120 subjects): 150×10\^6 PLX-PAD cells (10×10\^6 cells/mL) in a mixture containing 10% DMSO (v/v), 5% HSA (w/v) and PlasmaLyte
Placebo
Arm 2 Placebo (120 subjects): Placebo (solution comprised of 10% DMSO \[v/v\], 5% HSA \[w/v\], and PlasmaLyte, without cells).
"MHAT Ljulin Department of Orthopedy and Traumatology", Sofia
"MHAT Serdika Department of Orthopedy and Traumatology", Sofia
Military Medical Academy, Sofia
Specialized Hospital for Active Treatment in Orthopedy, Sofia
Charite - Campus Mitte,Campus Virchow-Klinikum, Berlin
ANTRIA, INC,300 Indian Springs Road,Indiana, Indiana
Meir Medical Center-Internal Medicine E;59 Tshernichovsky Street, Kfar Saba
Universitaetsklinikum Muenster, Münster
The Chaim Sheba Medical Center,Tel Hashomer, Ramat Gan
Sourasky Medical Center,6 Weizmann St; Harrison Building 6 Floor, Tel Aviv
Kaplan Medical Center,Pasternak St., P.O.B 1,Rehovot, Rehovot
Denver Metro Orthopedics, P.C. 499 E. Hampden Avenue, Suite 140 Englewood, CO 80113, Denver
University Of California Davis,4860 Y Street, Sacramento
Carmel Medical Center,7 Michal St, Haifa
Shaare Zedek Medical Center,The Orthopedic Department,Shmu'el Bait St. 12, Jerusalem
Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet Dresden, Dresden
John Radcliffe Hospital, Oxford
Pluristem Ltd.
INDUSTRY